Filters

Schizosaccharomyces pombe Putative methyltransferase-like protein C27D7.08c (SPAC27D7.08c)

Schizosaccharomyces pombe Putative methyltransferase-like protein C27D7.08c (SPAC27D7.08c) size: 100ug 2089

Supplier MBS RECOMBINANT PROTEINS
Price 2089
Size 100ug
Contact us Ask Component cell markers and DNA bp. markers are genetic markerser genes or DNA sequenceswith selection audit
Long name08c (SPAC27D7, 08c), Recombinant Schizosaccharomyces pombe Putative methyltransferase-like protein C27D7
Alternative names DUF890 family protein, Putative methyltransferase-like protein C27D7, 08c, DUF890 family protein
Gene name08c, SPAC27D7
Other gene names SPAC27D7, 08c, 08c, SPAC27D7
General description All of our recombinant proteins are manufactured in strictly controlled facilities and by using a well established technology which guarantees full batch-to-bact consistency and experiment reproducibility, The protein can be with or without a His-Tag or other tag in accordance to customer's request, 08c (SPAC27D7, 08c) is a recombinant protein expressed in Baculovirus , Putative methyltransferase-like protein C27D7
Product categoryRecombinant Proteins
Expression systemBaculovirus
Available also expressed in: Baculovirus , Mammalian Cell, Yeast , E Coli
PurityGreater than 90% (determined by SDS-PAGE)
FormLyophilized protein
Storage Avoid cycles of freezing and thawing as they might denaturate the polypeptide chains, For extended periods of time it is recommended to keep the protein frozen at -40 or -80 degrees Celsius, This protein can be stored at -20 degrees Celsius
Applications IFA, RIA, Western Blot, etc, This protein can be used as a positive control for applications such as ELISA
Gene target08c (SPAC27D7, 08c), Schizosaccharomyces pombe Putative methyltransferase-like protein C27D7
Short name08c (SPAC27D7, 08c), Schizosaccharomyces pombe Putative methyltransferase-like protein C27D7
Alternative name08c (SPAC27D7, 08c), Schizosaccharomyces pombe Putative methyltransferase-like protein C27D7

Similar products

Subscribe to our Newsletter